Zykadia was 1st FDA win for Novartis in San Diego

The Genomics Institute of the Novartis Research Foundation (GNF) in San Diego reached a major milestone in April with US FDA approval for the lung cancer drug Zykadia (ceritinib), because it was the first FDA approval for a compound discovered at GNF.